MedTrace Logo

Effects of a High Viscosity Dietary Fibre, as Part of a Medically Supervised Weight Management Program

NCT01387126 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2019-07-31

No results posted yet for this study

Summary

The aim of this study is to investigate whether the supplementation of a medically supervised weight management program with a novel fibre supplement, improves body weight, body composition, and laboratory measurements in overweight and obese individuals. All subjects will participate in the medical weight management program however the intervention group will have 5 grams of a novel fibre supplemented to each meal while the control group will not.

Conditions

Interventions

DIETARY_SUPPLEMENT

Novel fibre supplement

The full dose of the study intervention is 15 grams per day.

Sponsors & Collaborators

  • University of British Columbia

    collaborator OTHER

  • InovoBiologic Inc.

    collaborator INDUSTRY

  • Canadian Center for Functional Medicine

    lead OTHER

Principal Investigators

  • Michael R Lyon, MD · Canadian Centre for Functional Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01387126 on ClinicalTrials.gov